+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

From
From
Global Cell Isolation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Cell Isolation Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
From
Global Cell Dissociation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Cell Dissociation Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 160 Pages
  • Global
From
From
From
From
Holland-Frei Cancer Medicine. Edition No. 10 - Product Thumbnail Image

Holland-Frei Cancer Medicine. Edition No. 10

  • Book
  • April 2023
  • 2000 Pages
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more